PRESS RELEASE published on 05/07/2025 at 14:35, 1 year 6 months ago EQS-Adhoc: QIAGEN N.V.: QIAGEN to propose initiation of annual cash dividend for shareholder approval at Annual General Meeting QIAGEN N.V. to propose initiation of annual cash dividend at Annual General Meeting, aiming to enhance shareholder returns while ensuring growth. Initial dividend payment of $0.25 per share Annual General Meeting Shareholder Approval Dividend Policy Cash Dividend QIAGEN N.V.
BRIEF published on 04/06/2025 at 18:25, 1 year 7 months ago QIAGEN publie de solides résultats pour le premier trimestre 2025 et révise ses perspectives de bénéfice par action Croissance Des Ventes Nettes QIAGEN T1 2025 Perspectives De BPA Ventes De QuantiFERON Performances De QIAstat-Dx
BRIEF published on 04/06/2025 at 18:25, 1 year 7 months ago QIAGEN Reports Strong Q1 2025 Results and Revises EPS Outlook Net Sales Growth EPS Outlook QIAGEN Q1 2025 QuantiFERON Sales QIAstat-Dx Performance
PRESS RELEASE published on 04/06/2025 at 18:20, 1 year 7 months ago EQS-Adhoc: QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates full-year 2025 adjusted earnings per share outlook QIAGEN N.V. exceeds Q1 2025 outlook with 5% sales growth and raised full-year EPS guidance, driven by strong performance across growth drivers Preliminary Results Outlook Q1 2025 QIAGEN N.V. Adjusted Earnings Per Share
BRIEF published on 01/12/2025 at 19:00, 1 year 10 months ago QIAGEN prévoit un retour de 300 millions de dollars aux actionnaires via un rachat d'actions synthétique Rachat D'actions Actionnaires Remboursement Du Capital Regroupement D'actions QIAGEN
BRIEF published on 01/12/2025 at 19:00, 1 year 10 months ago QIAGEN Plans $300 Million Return to Shareholders via Synthetic Share Buyback Shareholders Share Buyback Reverse Stock Split QIAGEN Capital Repayment
PRESS RELEASE published on 01/12/2025 at 18:55, 1 year 10 months ago EQS-Adhoc: QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase QIAGEN N.V. to return approximately $300 million to shareholders through a synthetic share repurchase, enhancing earnings per share (EPS) and efficiency Shareholders Efficiency QIAGEN N.V. Synthetic Share Repurchase Earnings Per Share (EPS)
BRIEF published on 09/03/2024 at 08:00, 2 years 2 months ago QIAGEN N.V. Launches Non-US Offering of Convertible Bonds Convertible Bonds Bond Issuance Corporate Financing QIAGEN Non-US Offering
BRIEF published on 09/03/2024 at 08:00, 2 years 2 months ago QIAGEN NV lance une offre d'obligations convertibles hors des États-Unis Obligations Convertibles Emission D'obligations Financement Des Entreprises QIAGEN Offre Non Américaine
PRESS RELEASE published on 09/03/2024 at 07:55, 2 years 2 months ago EQS-Adhoc: QIAGEN N.V.: QIAGEN N.V. launches non-US offering of net share settled convertible bonds QIAGEN N.V. launches non-US offering of net share settled convertible bonds. Offering of USD 450 million convertible bonds due 2031 to institutional investors Convertible Bonds Institutional Investors Offering QIAGEN N.V. Net Share Settled
Published on 11/17/2026 at 15:00, 3 hours 15 minutes ago Secure Blockchain's Agentic Solutions Signs Engineering Company, Expanding Enterprise AI Into Heavy Industry
Published on 11/17/2026 at 14:45, 3 hours 30 minutes ago NanoViricides, Inc. Has Filed its Quarterly Report - Broad-Spectrum Antiviral Drug NV-387 Oral Gummies Has Entered Two Separate Phase II Clinical Trials - One to Treat Ebola Bundibugyo Virus Disease, and Another to Treat Mpox (Monkeypox)
Published on 11/17/2026 at 14:00, 4 hours 15 minutes ago FaZe Esports, a GameSquare Company, Wins Rainbow Six Championship at Osaka Major
Published on 11/17/2026 at 14:00, 4 hours 15 minutes ago Tectonic Metals Completes Record Drill Program at Flat, Advances Five Pillars of Growth Toward Major 2027 Milestones
Published on 11/17/2026 at 17:54, 20 minutes ago SKAN takes note of the Federal Criminal Court’s first-instance judgments
Published on 11/17/2026 at 17:45, 30 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 11/17/2026 at 17:39, 36 minutes ago Disclosure according to Article 5(1)(b) of EU Regulation No. 596/2014 and Article 2(3) of Delegated EU Regulation No. 2016/1052 - 2nd Interim Report
Published on 11/17/2026 at 18:00, 15 minutes ago 20261117 - Accor - Accor to increase its stake in Ennismore
Published on 11/17/2026 at 17:45, 30 minutes ago EURAZEO COMPLETES THE SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT ALONGSIDE PARTNERS GROUP
Published on 11/17/2026 at 17:45, 30 minutes ago EURAZEO FINALISE LA CESSION DE SA PARTICIPATION DANS AROMA-ZONE ET SON REINVESTISSEMENT AUX COTES DE PARTNERS GROUP
Published on 11/17/2026 at 07:40, 10 hours 34 minutes ago SUEZ INTERNATIONAL SAS COMPLETES THE SALE OF C.10.65 MILLION SHARES OF ACEA S.P.A.